Topiramate Capsule, Extended Release
Product Images NDC 0480-2359

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 0480-2359). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

FDA Label Image

1 (Image 2)

FDA Label Image

2 (Image 3)

This is a not-available text as there is not enough meaningful information to generate a description. The text seems to contain medical terms and dosage information, but it is incomplete and disorganized.*

FDA Label Image

Label-200mg-30s (Image 4)

This is a medication called Topiramate, which comes in the form of extended-release capsules with a strength of 200mg. It is intended to be taken once daily and should not be crushed or sprinkled on food. It is important to provide each patient with the accompanying Medication Guide. The prescribed dosage should be determined by referring to the package insert. The medication should be stored in a cool, dry place and kept out of reach of children. It is manufactured in Bulgaria by Balkanpharma Dupnitsa AD for Teva Pharmaceuticals in Parsippany, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.